Spots Global Cancer Trial Database for cervical squamous cell carcinoma
Every month we try and update this database with for cervical squamous cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer | NCT00217633 | Cervical Adenoc... Cervical Adenos... Cervical Small ... Cervical Squamo... Recurrent Cervi... | Conventional Su... | 18 Years - | GOG Foundation | |
| Complete Nerve-Sparing Radical Hysterectomy for Cervical Cancer | NCT02562729 | Cervical Squamo... Cervical Adenoc... Malignant Neopl... Stage IIA1 Cerv... | Nerve-Sparing R... | 18 Years - 70 Years | Shanghai Gynecologic Oncology Group | |
| Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer | NCT00057863 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... Recurrent Cervi... Stage IVA Cervi... Stage IVB Cervi... | Paclitaxel Oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix | NCT00004866 | Cervical Cancer | exatecan mesyla... | 18 Years - | Daiichi Sankyo | |
| Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer | NCT00691301 | Cervical Cancer | cisplatin pemetrexed diso... | - 120 Years | GOG Foundation | |
| Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors | NCT00066651 | Cervical Cancer Fallopian Tube ... Head and Neck C... Lung Cancer Malignant Mesot... Ovarian Cancer Pancreatic Canc... Primary Periton... | SS1(dsFv)-PE38 ... | 18 Years - | National Cancer Institute (NCI) | |
| MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients | NCT00004936 | Cervical Cancer | iodinated contr... computed tomogr... magnetic resona... gadopentetate d... | - | American College of Radiology Imaging Network | |
| Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer | NCT00462397 | Cervical Cancer | carboplatin cisplatin paclitaxel neoadjuvant the... brachytherapy radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy and Cisplatin With or Without Amifostine for Patients With Stage IIIB or IVA Cervical Cancer | NCT00012012 | Cervical Cancer Radiation Toxic... | Amifostine trih... Cisplatin Intracavitary b... External beam r... | 18 Years - | Radiation Therapy Oncology Group | |
| Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer | NCT00002813 | Cervical Cancer | cisplatin vinorelbine tar... | - | GOG Foundation | |
| Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer | NCT00023660 | Cervical Cancer | celecoxib cisplatin fluorouracil brachytherapy radiation thera... | 18 Years - 85 Years | Radiation Therapy Oncology Group | |
| Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer | NCT00101192 | Cervical Cancer | cetuximab cisplatin | 18 Years - | GOG Foundation | |
| Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix | NCT00031993 | Cervical Squamo... Recurrent Cervi... | erlotinib hydro... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer | NCT00499031 | Cervical Squamo... Recurrent Cervi... | Cetuximab | 18 Years - | GOG Foundation | |
| Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer | NCT00101192 | Cervical Cancer | cetuximab cisplatin | 18 Years - | GOG Foundation | |
| Complete Nerve-Sparing Radical Hysterectomy for Cervical Cancer | NCT02562729 | Cervical Squamo... Cervical Adenoc... Malignant Neopl... Stage IIA1 Cerv... | Nerve-Sparing R... | 18 Years - 70 Years | Shanghai Gynecologic Oncology Group | |
| Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia | NCT00017004 | Anemia Cervical Adenoc... Cervical Adenos... Cervical Squamo... Drug Toxicity Radiation Toxic... Stage IIB Cervi... Stage III Cervi... Stage IVA Cervi... | External Beam R... Cisplatin Internal Radiat... Epoetin Alfa | - | GOG Foundation | |
| Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer | NCT00070317 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... Stage I Cervica... | Isosulfan Blue Lymph Node Mapp... Lymphangiograph... Methylene Blue Radionuclide Im... Sentinel Lymph ... Technetium Tc-9... Therapeutic Con... | - | GOG Foundation | |
| Radiation Therapy in Treating Patients With Cervical Cancer | NCT00278304 | Cervical Cancer | brachytherapy radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer | NCT00003369 | Cervical Cancer | cisplatin tirapazamine | 18 Years - | SWOG Cancer Research Network | |
| Carboplatin and Paclitaxel With or Without Cediranib Maleate in Treating Patients With Metastatic or Recurrent Cervical Cancer That Cannot Be Removed by Surgery | NCT01229930 | Cervical Cancer | carboplatin cediranib malea... paclitaxel laboratory biom... pharmacological... quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer | NCT00054444 | Cervical Adenoc... Cervical Squamo... Stage IB Cervic... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage IVA Cervi... | Topotecan Hydro... 3-Dimensional C... Cisplatin | - | GOG Foundation | |
| Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix | NCT00003078 | Cervical Cancer | cisplatin fluorouracil brachytherapy radiation thera... | - | GOG Foundation | |
| Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix | NCT00003377 | Cervical Cancer | cisplatin paclitaxel brachytherapy radiation thera... | 18 Years - | GOG Foundation | |
| Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer | NCT00039338 | Cervical Cancer | conventional su... neoadjuvant che... brachytherapy radiation thera... cisplatin | 18 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer | NCT00054444 | Cervical Adenoc... Cervical Squamo... Stage IB Cervic... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage IVA Cervi... | Topotecan Hydro... 3-Dimensional C... Cisplatin | - | GOG Foundation | |
| Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery | NCT00331760 | Cervical Cancer Endometrial Can... | cisplatin intensity-modul... | 18 Years - | Radiation Therapy Oncology Group | |
| Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer | NCT00016926 | Cervical Cancer | capecitabine | - | GOG Foundation | |
| S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer | NCT00003369 | Cervical Cancer | cisplatin tirapazamine | 18 Years - | SWOG Cancer Research Network | |
| Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia | NCT00017004 | Anemia Cervical Adenoc... Cervical Adenos... Cervical Squamo... Drug Toxicity Radiation Toxic... Stage IIB Cervi... Stage III Cervi... Stage IVA Cervi... | External Beam R... Cisplatin Internal Radiat... Epoetin Alfa | - | GOG Foundation | |
| Epoetin Beta in Treating Anemia in Patients With Cervical Cancer | NCT00046969 | Anemia Cervical Cancer | epoetin beta cisplatin brachytherapy radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer | NCT00026260 | Cervical Cancer | semaxanib | - | National Cancer Institute (NCI) | |
| Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer | NCT01590017 | Cervical Cancer Acquired Immuno... | cisplatin external beam r... | 18 Years - 120 Years | AIDS Malignancy Consortium | |
| Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer | NCT00054444 | Cervical Adenoc... Cervical Squamo... Stage IB Cervic... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage IVA Cervi... | Topotecan Hydro... 3-Dimensional C... Cisplatin | - | GOG Foundation | |
| Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia | NCT00017004 | Anemia Cervical Adenoc... Cervical Adenos... Cervical Squamo... Drug Toxicity Radiation Toxic... Stage IIB Cervi... Stage III Cervi... Stage IVA Cervi... | External Beam R... Cisplatin Internal Radiat... Epoetin Alfa | - | GOG Foundation | |
| Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer | NCT00057863 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... Recurrent Cervi... Stage IVA Cervi... Stage IVB Cervi... | Paclitaxel Oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage IB, Stage II, or Stage IIIB Cervical Cancer | NCT00957411 | Cervical Cancer | cetuximab cisplatin | 18 Years - 120 Years | Institut Curie | |
| Cyclooxygenase-2 Expression in Tissue Samples From Patients With a Normal Cervix, Cervical Intraepithelial Neoplasia, or Early Invasive Cervical Cancer | NCT00900081 | Cervical Cancer Precancerous Co... | immunohistochem... laboratory biom... medical chart r... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer | NCT00005837 | Cervical Cancer | oxaliplatin | - | National Cancer Institute (NCI) | |
| Cisplatin and Radiation Therapy With or Without Hyperthermia Therapy in Treating Patients With Cervical Cancer | NCT00085631 | Cervical Cancer | cisplatin hyperthermia tr... brachytherapy external beam r... | 18 Years - | Duke University | |
| Application of PLDR External Irradiation Combined With Immune Checkpoint Inhibitors in Recurrent Cervical Cancer | NCT06232083 | Cervical Squamo... Radiotherapy Immunotherapy | PLDR+Cardunizum... | 20 Years - 70 Years | Anhui Provincial Hospital | |
| Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer | NCT01649089 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... Lymphedema Stage IA1 Cervi... Stage IA2 Cervi... Stage IB1 Cervi... | Conization Quality-of-Life... Questionnaire A... Therapeutic Con... Therapeutic Lym... | 18 Years - | GOG Foundation | |
| Study of Nimotuzumab Combined With IMRT in Elder Patients With Cervical Squamous Cell Carcinoma | NCT04976478 | Cervical Squamo... | Nimotuzumab EBRT combined w... | 65 Years - | Peking University Third Hospital | |
| Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer | NCT00287911 | Cervical Cancer | cisplatin topotecan hydro... brachytherapy radiation thera... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer | NCT00003379 | Cervical Cancer | cisplatin paclitaxel brachytherapy radiation thera... | 18 Years - | GOG Foundation | |
| Primary Cervical Cancer Screening by Self-sampling HPV Test | NCT05613283 | Human Papilloma... Cervical Cancer Negative For In... Atypical Squamo... Atypical Squamo... Cervical Squamo... Low-Grade Squam... High-Grade Squa... Cervical Intrae... Cervical Intrae... Cervical Intrae... Atypical Glandu... Atypical Glandu... Atypical Glandu... Cervical Squamo... Adenocarcinoma ... Cervical Adenoc... | 21 Years - 65 Years | Peking University People's Hospital | ||
| Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer | NCT00217633 | Cervical Adenoc... Cervical Adenos... Cervical Small ... Cervical Squamo... Recurrent Cervi... | Conventional Su... | 18 Years - | GOG Foundation | |
| Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer | NCT00039338 | Cervical Cancer | conventional su... neoadjuvant che... brachytherapy radiation thera... cisplatin | 18 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage IB, Stage II, or Stage IIIB Cervical Cancer | NCT00957411 | Cervical Cancer | cetuximab cisplatin | 18 Years - 120 Years | Institut Curie | |
| Immunotoxin Therapy in Treating Patients With Advanced Cancer | NCT00006981 | Cervical Cancer Fallopian Tube ... Head and Neck C... Lung Cancer Malignant Mesot... Ovarian Cancer Pancreatic Canc... Primary Periton... | SS1(dsFv)-PE38 ... | 18 Years - | National Cancer Institute (NCI) | |
| Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer | NCT01266447 | Cervical Adenoc... Cervical Adenos... Cervical Small ... Cervical Squamo... Recurrent Cervi... Stage III Cervi... Stage IVA Cervi... Stage IVB Cervi... | Filgrastim Laboratory Biom... Pegfilgrastim Topotecan Hydro... Veliparib | 18 Years - | National Cancer Institute (NCI) | |
| Oral Rigosertib for Squamous Cell Carcinoma | NCT01807546 | Head and Neck S... Anal Squamous C... Lung Squamous C... Cervical Squamo... Esophageal Squa... Skin Squamous C... Penile Squamous... | rigosertib | 18 Years - | Traws Pharma, Inc. | |
| Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer | NCT00276796 | Cervical Cancer | cisplatin paclitaxel topotecan hydro... | 18 Years - | GOG Foundation | |
| Carboplatin and Topotecan in Treating Patients With Relapsed or Metastatic Cervical Cancer | NCT00807079 | Cervical Cancer | carboplatin topotecan hydro... | 18 Years - | ARCAGY/ GINECO GROUP | |
| Cyclooxygenase-2 Expression in Tissue Samples From Patients With a Normal Cervix, Cervical Intraepithelial Neoplasia, or Early Invasive Cervical Cancer | NCT00900081 | Cervical Cancer Precancerous Co... | immunohistochem... laboratory biom... medical chart r... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Docetaxel in Treating Patients With Advanced Cancer of the Cervix | NCT00003445 | Cervical Cancer | docetaxel | - | National Cancer Institute (NCI) | |
| Radiation Therapy in Treating Patients With Cervical Cancer | NCT00278304 | Cervical Cancer | brachytherapy radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer | NCT00068549 | Cervical Adenoc... Cervical Adenos... Cervical Small ... Cervical Squamo... Stage IB Cervic... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage IVA Cervi... | Gemcitabine Hyd... Cisplatin Radiation Thera... Internal Radiat... | - | GOG Foundation | |
| MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients | NCT00004936 | Cervical Cancer | iodinated contr... computed tomogr... magnetic resona... gadopentetate d... | - | American College of Radiology Imaging Network | |
| Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer | NCT03738228 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... Stage IB2 Cervi... Stage II Cervic... Stage IIA Cervi... Stage IIA1 Cerv... Stage IIA2 Cerv... Stage IIB Cervi... Stage IIIB Cerv... Stage IVA Cervi... | Atezolizumab Brachytherapy Cisplatin Radiation Thera... | 18 Years - | National Cancer Institute (NCI) | |
| Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer | NCT00276796 | Cervical Cancer | cisplatin paclitaxel topotecan hydro... | 18 Years - | GOG Foundation | |
| Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery | NCT01026792 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... Recurrent Cervi... Stage IIIA Cerv... Stage IIIB Cerv... Stage IVA Cervi... Stage IVB Cervi... | Temsirolimus Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer | NCT00039338 | Cervical Cancer | conventional su... neoadjuvant che... brachytherapy radiation thera... cisplatin | 18 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer | NCT00691301 | Cervical Cancer | cisplatin pemetrexed diso... | - 120 Years | GOG Foundation | |
| Immunotoxin Therapy in Treating Patients With Advanced Cancer | NCT00006981 | Cervical Cancer Fallopian Tube ... Head and Neck C... Lung Cancer Malignant Mesot... Ovarian Cancer Pancreatic Canc... Primary Periton... | SS1(dsFv)-PE38 ... | 18 Years - | National Cancer Institute (NCI) | |
| Dose Escalation Study of Simultaneous Boost Intensity-Modulated Radiotherapy for Locally Advanced Cervical Cancer | NCT01230996 | Locally Advance... | Cisplatin Intensity-modul... Intracavitary b... | 18 Years - 65 Years | Barts & The London NHS Trust | |
| Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer | NCT01649089 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... Lymphedema Stage IA1 Cervi... Stage IA2 Cervi... Stage IB1 Cervi... | Conization Quality-of-Life... Questionnaire A... Therapeutic Con... Therapeutic Lym... | 18 Years - | GOG Foundation | |
| Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer | NCT00005999 | Cervical Cancer | arsenic trioxid... | 17 Years - | National Cancer Institute (NCI) | |
| Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix | NCT00064077 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... Recurrent Cervi... Stage IVB Cervi... | Cisplatin Gemcitabine Hyd... Paclitaxel Quality-of-Life... Topotecan Hydro... Vinorelbine Tar... | 18 Years - | GOG Foundation | |
| Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers | NCT02466971 | Advanced Vagina... Advanced Vagina... Advanced Vagina... Cervical Adenoc... Cervical Adenos... Cervical Squamo... Stage IB2 Cervi... Stage II Cervic... Stage II Vagina... Stage IIA Cervi... Stage IIB Cervi... Stage III Vagin... Stage IIIB Cerv... Stage IV Vagina... Stage IVA Cervi... Stage IVA Vagin... Unresectable Va... Vaginal Adenoca... Vaginal Adenosq... Vaginal Carcino... Vaginal Squamou... | Brachytherapy Cisplatin External Beam R... Intensity-Modul... Laboratory Biom... Radiation Thera... Triapine | 18 Years - | National Cancer Institute (NCI) | |
| Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer | NCT00262821 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... Stage IB Cervic... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage IVA Cervi... | cisplatin tirapazamine | 18 Years - | National Cancer Institute (NCI) | |
| Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer | NCT00087126 | Cervical Cancer | topotecan hydro... | 18 Years - 120 Years | GOG Foundation | |
| Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer | NCT00104910 | Cervical Adenoc... Cervical Adenos... Cervical Small ... Cervical Squamo... Stage IB Cervic... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage IVA Cervi... | Internal Radiat... 3-Dimensional C... Cetuximab Cisplatin | 18 Years - | GOG Foundation | |
| Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix | NCT00006482 | Cervical Cancer | cisplatin gemcitabine hyd... | - | GOG Foundation | |
| Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia | NCT00017004 | Anemia Cervical Adenoc... Cervical Adenos... Cervical Squamo... Drug Toxicity Radiation Toxic... Stage IIB Cervi... Stage III Cervi... Stage IVA Cervi... | External Beam R... Cisplatin Internal Radiat... Epoetin Alfa | - | GOG Foundation | |
| Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer | NCT00691301 | Cervical Cancer | cisplatin pemetrexed diso... | - 120 Years | GOG Foundation | |
| Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix | NCT00030472 | Cervical Cancer | pegylated lipos... | - | GOG Foundation | |
| Cisplatin Combined With Radiation Therapy and Hyperthermia in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer | NCT00008112 | Cervical Cancer | cisplatin hyperthermia tr... brachytherapy radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer | NCT00068549 | Cervical Adenoc... Cervical Adenos... Cervical Small ... Cervical Squamo... Stage IB Cervic... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage IVA Cervi... | Gemcitabine Hyd... Cisplatin Radiation Thera... Internal Radiat... | - | GOG Foundation | |
| Epoetin Beta in Treating Anemia in Patients With Cervical Cancer | NCT00046969 | Anemia Cervical Cancer | epoetin beta cisplatin brachytherapy radiation thera... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
